06 Dec 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Executive director of DIA, Mr Paul Pomerantz is quitting his position effective March 3, 2013, to assume the role of CEO for the American Society of Anesthesiologists. During the next three months, Mr Pomerantz will work closely with DIA's board of directors to execute a smooth transition that sustains the momentum the organization has achieved under his leadership.
DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and lifecycle management of pharmaceuticals, biotechnology, medical devices and related healthcare products. Headquartered in US, DIA has presence in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington DC, US; and Latin America.
"Paul has been an extraordinary executive director who will be sorely missed, but together we have built a strong foundation for continued growth," said DIA president Dr Ling Su. "We are committed to continue the implementation of our strategic plan, which is bringing quality programs and services to our members and stakeholders globally. We thank Paul for his contributions and wish him the best of success in his new position."
Under the leadership of Mr Pomerantz, DIA has achieved rapid global expansion and significantly increased its stakeholder relationships-particularly among global health organizations, regulatory agencies and patient groups-driving its transformation into a world-class, knowledge-driven organization.
"This was a very difficult decision to make," Mr Pomerantz said. "The last three years have been among the most fulfilling of my professional career. I am proud of what we accomplished, and I am confident that DIA's board of directors, staff and volunteers will continue our progress. My new position provides an exciting challenge to serve the needs of a leading medical association and its patients."